期刊文献+

Von Hippel—Lindau综合征的临诊应对 被引量:3

Approach to the patients with von Hippel-Lindau syndrome
原文传递
导出
摘要 Von Hippel-Lindau(VHL)综合征是一种常染色体显性遗传的家族性多系统肿瘤综合征,为VHL基因突变或缺失所致。本文通过对1例VHL综合征患者的临床特点进行分析,并就该病发病机制、临床表现、基因诊断以及治疗的国内外研究进展进行讨论,以加深临床医师对本病的认识。 Von Hippel-Lindau(VHL)syndrome is an autosomal-dominant hereditary cancer syndrome caused by germline mutations or deletions in the VHL gene. We present a case with VHL syndrome, regarding the pathogenesis, clinical manifestation, genetic diagnosis and treatment, so as to help further understand this syndrome.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2013年第4期344-348,共5页 Chinese Journal of Endocrinology and Metabolism
关键词 Von Hippel-Lindau综合征 VHL基因 诊断 治疗 Von Hippel-Lindau syndrome VHL gene Diagnosis Treatment
  • 相关文献

参考文献20

  • 1Richard S, David P, Marsot D, et al. Central nerveous system hemangioblastomas, endolymphatic sac tumours, and Von Hippel Lindau disease. Neurosurg Rev, 2000,23 : 1-22.
  • 2Latif F, Tory K, Gnarra J, et al. Identification of the yon Hippel-Lindau disease tumor suppressor gene. Science, 1993,260 : 1317-1320.
  • 3Okuda H, Saitoh K, Hirai S, et al. The von Hippel-Lindau tumor suppressor protein mediates ubiquitination of activated atypical protein kinase C. J Biol Chem, 2001,276:43611-43617.
  • 4Kaelin WG Jr. The von Hippel-Lindau gene, kidney cancer, and oxygen sensing. J Am Sac Nephrol, 2003,14:2703-2711.
  • 5Schnell PO, lgnaeak ML, Bauer AL, et ah Regulation of tyrosine hydroxylase promoter activity by the von Hippel-Lindau tumor suppressor protein and hypoxia-inducible transcription factors. J Nenrochem, 2003,85:483-491.
  • 6Lee S, Nakamura E, Yang H, et al. Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial Pheo genes: developmental culling and cancer. Cancer Cell, 2005,8 : 155-167.
  • 7Calzada MJ. Von Hippel-Lindau syndrome: molecular mechanisms of the disease. Clin Transl Oncol, 2010,12 : 160-165.
  • 8Barontini M, Dahia PL. VHL disease. Best Pract Res Clin Endocrinol Metab, 2010,24:401-413.
  • 9Wanebo JE, Lonser RR, Glenn GM, et al. The natural history of hemm-,giohlastomas of the central nervous system in patients with von Hippel-Lindau disease. J Neurosurg, 2003,98:82-94.
  • 10Singh AD, Nouri M, Shields CL, et al. Treatment of retinal capillary hemangioma. Ophthalmology, 2002,109 : 1799-1806.

同被引文献21

  • 1张弋,李进,王健,孙玉成,高伟,王升晗,崔昕.Vov Hippel-Lindau病肾肿瘤九例临床分析[J].中华外科杂志,2007,45(14):994-995. 被引量:1
  • 2Maher ER, Neumann HP, Richard S. von Hippel- Lindau disease: A clinical and scientific review [J]. Eur J Hum Genet, 2011, 19(6) : 617-623.
  • 3Richard S, Graft J, Lindau J, et al. Von Hippel-Lindau disease[J]. Lancet, 2004, 363(9416): 1231-1234.
  • 4Lonser RR, Glenn GM, Walther M, et al. Von Hippel- Lindau disease[J]. Lancet, 2003, 361(9374): 2059- 2067.
  • 5Richard S, David P, Marsot-Dupuch K, et al. Central nervous system hemangioblastomas, endolymphatic sac tumors, and yon Hippel-Lindau disease[J]. Neurosurg Rev, 2000, 23 (1) : 23-24.
  • 6Maher ER, Iselius L, Yates JR, et al. Von Hippe!- Lindau disease: a genetic study [J]. J Med Genet, 1991, 28(7): 443-447.
  • 7Lane CM, Turner G, Gregor ZJ, et al. Laser treatment of retinal angiomatosis [J]. Eye (Lond), 1989, 3 (Pt 1) : 33-38.
  • 8Hes FJ, van der Luijt RB, Lips CJ. Clinical management of Von Hippel-Lindau (VHL) disease [ J ]. Neth J Med, 2001, 59(5): 225-234.
  • 9Clifford SC, Maher ER. Von Hippel-Lindau disease: clinical and molecular perspectives [J]. Adv Cancer Res, 2001, 82(2): 85-105.
  • 10Singh AD, Nouri M, Shields CL, et al. Retinal capillary hemangioma : a comparison of sporadic cases and cases associated with yon Hippel-Lindau disease [J]. Ophthalmology, 2001, 108(10) : 1907-1911.

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部